| 1. | | Recruiting | A 24 Week Study of Daily Oral Investigational Drug vs Placebo in Patients with Asthma
Condition: Asthma |
| 2. | | Not yet recruiting | Anti-angiogenesis Agent AG-013736 in Patients with Advanced Non-Small Cell Lung Cancer
Conditions: Non-Small-Cell Lung Carcinoma; Metastases |
| 3. | | Not yet recruiting | Anti-angiogenesis Agent AG-013736 in Patients with Metastatic Melanoma
Conditions: Melanoma; Metastases |
| 4. | | Recruiting | Antibiotic Treatment for Patients with Infections of Short Term In-dwelling Vascular Catheters Due to a Specific Bacteria (Gram Positive Bacteria)
Conditions: Bacterial Infections; Gram-Positive Bacterial Infections; Bacteremia |
| 5. | | Not yet recruiting | Azithromycin in Combination with Chloroquine Versus Chloroquine in the Eradication of Asymptomatic Plasmodium Falciparum Infection in Semi-Immune Adults
Condition: Plasmodium falciparum Malaria |
| 6. | | Recruiting | Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America
Condition: Plasmodium falciparum Malaria |
| 7. | | Recruiting | Azithromycin Plus Chloroquine Versus Mefloquine for the Treatment of Uncomplicated Malaria in Uganda
Condition: Plasmodium falciparum Malaria |
| 8. | | Recruiting | Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Jakarta, Indonesia
Condition: Plasmodium falciparum Malaria |
| 9. | | Recruiting | CP-675,206 in Patients with Advanced Melanoma
Condition: Melanoma |
| 10. | | Recruiting | Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease
Condition: Alzheimer Disease |
| 11. | | Recruiting | Efficacy and Safety of SU011248 in Patients with Anthracycline- and Taxane-Refractory Metastatic Breast Cancer
Conditions: Breast Cancer; Neoplasm Metastasis |
| 12. | | Recruiting | Eplerenone on Cardiac Remodeling in Patients with Left Ventricular Systolic Dysfunction and Mild to Moderate Heart Failure
Condition: Congestive Heart Failure |
| 13. | | Recruiting | FLASH Study: A study of roflumilast versus placebo in patients with asthma
Condition: Asthma |
| 14. | | Recruiting | Intravenous Edotecarin in Patients with Advanced Gastric Cancer that has Progressed or Recurred After Prior Fluoropyrimidine-based Chemotherapy
Condition: Gastric Cancer |
| 15. | | Recruiting | Intravitreous Pegaptanib Sodium Injection in patients with Exudative Age-Related Macular Degeneration (AMD)
Condition: Macular Degeneration |
| 16. | | Recruiting | Investigational Cancer Drug in Women with Metastatic Breast Cancer whose Cancer has Gotten Worse after Anthracycline and Taxane Therapy
Conditions: Breast Neoplasms; Neoplasm Metastasis |
| 17. | | Not yet recruiting | An Investigational Drug in Subjects with Subfoveal Choroidal Neovascularization Associated with Age-related Macular Degeneration
Condition: Macular Degeneration |
| 18. | | Recruiting | Investigational Drug with Neoadjuvant Hormone Therapy in Patients with High Risk Prostate Cancer
Condition: Prostate Cancer |
| 19. | | Not yet recruiting | Linezolid in the Treatment of Complicated Skin and Soft Tissue due to Methicillin-Resistant Staphylococcus Aureus
Conditions: Staphylococcal Skin Infections; Soft Tissue Infections |
| 20. | | Not yet recruiting | Linezolid In The Treatment Of Subjects With Nosocomial Pneumonia Proven To Be Due To Methicillin-Resistant Staphylococcus Aureus
Condition: Pneumonia |
| 21. | | Recruiting | New Antibiotic to Treat Pediatric Patients with Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus)
Condition: Bacterial Infections |
| 22. | | Recruiting | OPUS Study: Effect of Roflumilast on exacerbation rate in patients with chronic obstructive pulmonary disease
Condition: Chronic Obstructive Pulmonary Disease |
| 23. | | Recruiting | Oral Study Drug in Patients with Advanced Metastatic Breast Cancer who have Experienced Failure of an Anthracycline, a Taxane, and Capecitabine
Conditions: Breast Cancer; Neoplasm Metastasis |
| 24. | | Recruiting | Oral Tyrosine Kinase Inhibitor of VEGFR-2 to Treat Recurrent or Persistent Small-volume Epithelial Ovarian Cancer, Primary Peritoneal Serous Cancer, or Fallopian Tube Cancer
Condition: Ovarian Cancer |
| 25. | | Recruiting | Osteoarthritis Initiative (OAI): A Knee Health Study
Conditions: Osteoarthritis; Knee Osteoarthritis |
| 26. | | Recruiting | PCI plus intensive medical therapy will be superior to intensive medical therapy alone in reducing all cause mortality or nonfatal MI
Condition: Myocardial Ischemia |
| 27. | | Recruiting | Pegaptanib Sodium Compared to Sham Injection in Patients with Recent Vision Loss due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO)
Condition: Macular Degeneration |
| 28. | | Recruiting | Pegaptanib Sodium on Foveal Thickening in Patients with Exudative Subfoveal Age-related Macular Degeneration (AMD)
Condition: Macular Degeneration |
| 29. | | Recruiting | Pegvisomant and Sandostatin LAR Combination Study
Condition: Acromegaly |
| 30. | | Recruiting | Prevention of cognitive decline in Alzheimer's disease by ingested interferon alpha
Conditions: Memory Disorders; Alzheimer's Disease |
| 31. | | Recruiting | Rebif® versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis
Condition: Relapsing-Remitting Multiple Sclerosis |
| 32. | | Recruiting | Study Drug in Combination with Docetaxel versus Docetaxel Alone for Patients with Metastatic Breast Cancer
Condition: Breast Cancer |
| 33. | | Recruiting | Study of an Oral Tyrosine Kinase Inhibitor of VEGFR-2 for the Treatment of Advanced Stage Non-small Cell Lung Cancer
Conditions: Lung Cancer; Carcinoma, Non-Small-Cell Lung |
| 34. | | Not yet recruiting | Study of SU011248 in Patients with Metastatic Non-Small Cell Lung Cancer
Condition: Non-Small-Cell Lung Carcinoma |
| 35. | | Recruiting | Study of SU011248 in Patients with Neuroendocrine Tumors
Conditions: Neuroendocrine Tumor; Carcinoid Tumor |
| 36. | | Recruiting | Study of the Anti-angiogenesis Agent AG-013736 in Patients with Metastatic Thyroid Cancer
Conditions: Thyroid Cancer; Metastases |
| 37. | | Recruiting | A Study to Compare the Efficacy and Safety of Pegvisomant to that of Sandostatin LAR in Patients with Acromegaly
Condition: Acromegaly |
| 38. | | Recruiting | A Study to Evaluate the Efficacy and Safety of a New Research Medication in Subjects with an Acute Stroke
Condition: Acute Stroke |
| 39. | | Recruiting | SU011248 in Patients with Malignant Gastrointestinal Stromal Tumor (GIST) That Have Progressed During or Not Tolerated Treatment with Imatinib Mesylate (GLEEVEC™)
Condition: Gastrointestinal Neoplasms |
| 40. | | Recruiting | SU011248 in Patients with Metastatic Colorectal Cancer who Previously Failed Treatment with Irinotecan-, Oxaliplatin-, and Fluoropyrimidine, with and without Bevacizumab
Conditions: Colorectal Cancer; Neoplasm Metastasis |
| 41. | | Not yet recruiting | SU011248 in the Treatment of Patients with Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma
Condition: Renal Cell Carcinoma |
| 42. | | Recruiting | SU011248 in the Treatment of Patients with Cytokine-Refractory Metastatic Renal Cell Carcinoma
Condition: Renal Cell Carcinoma |
| 43. | | Recruiting | SU011248 versus Interferon-alfa as First-Line Systemic Therapy for Patients with Metastatic Renal Cell Carcinoma
Condition: Renal Cell Carcinoma |
| 44. | | Not yet recruiting | A Treatment Protocol for Patients with Gastrointestinal Stromal Tumor (GIST) who May Derive Benefit from Treatment with SU011248
Condition: Gastrointestinal Neoplasm |
| 45. | | Recruiting | Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Malaria in India
Condition: Plasmodium falciparum Malaria |
